Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alimera Sciences Inc (ALIM)

Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 180,098
  • Shares Outstanding, K 52,354
  • Annual Sales, $ 80,750 K
  • Annual Income, $ -20,130 K
  • 60-Month Beta 1.18
  • Price/Sales 2.30
  • Price/Cash Flow N/A
  • Price/Book 4.06
Trade ALIM with:

Options Overview Details

View History
  • Implied Volatility 302.45% ( +112.34%)
  • Historical Volatility 49.36%
  • IV Percentile 92%
  • IV Rank 67.61%
  • IV High 436.20% on 02/26/24
  • IV Low 23.33% on 10/25/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 30
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 1.67
  • Today's Open Interest 80
  • Open Int (30-Day) 48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +94.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.27 +11.01%
on 04/18/24
4.24 -14.38%
on 03/25/24
-0.42 (-10.37%)
since 03/19/24
3-Month
3.07 +18.24%
on 02/21/24
4.27 -14.99%
on 03/15/24
-0.31 (-7.87%)
since 01/19/24
52-Week
1.56 +132.69%
on 05/12/23
4.38 -17.12%
on 01/02/24
+1.55 (+74.78%)
since 04/19/23

Most Recent Stories

More News
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 3.63 (+5.52%)
Alimera Sciences: Q3 Earnings Snapshot

Alimera Sciences: Q3 Earnings Snapshot

ALIM : 3.63 (+5.52%)
Alimera Sciences: Q2 Earnings Snapshot

Alimera Sciences: Q2 Earnings Snapshot

ALIM : 3.63 (+5.52%)
Alimera Sciences: Q1 Earnings Snapshot

Alimera Sciences: Q1 Earnings Snapshot

ALIM : 3.63 (+5.52%)
ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of 40% and 16.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 3.86 (+1.85%)
ALIM : 3.63 (+5.52%)
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates

ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of 7.50% and 5.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ADCT : 4.84 (+1.68%)
ALIM : 3.63 (+5.52%)
Will Alimera Sciences (ALIM) Report Negative Q1 Earnings? What You Should Know

Alimera Sciences (ALIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALIM : 3.63 (+5.52%)
CDXS : 2.86 (+2.14%)
Alimera Sciences (ALIM) Reports Q4 Loss, Misses Revenue Estimates

Alimera Sciences (ALIM) delivered earnings and revenue surprises of -92.86% and 11.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ALIM : 3.63 (+5.52%)
AMGN : 264.92 (+0.83%)
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 3.63 (+5.52%)
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SYBX : 1.8600 (+1.64%)
ALIM : 3.63 (+5.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes...

See More

Key Turning Points

3rd Resistance Point 4.03
2nd Resistance Point 3.85
1st Resistance Point 3.64
Last Price 3.63
1st Support Level 3.25
2nd Support Level 3.07
3rd Support Level 2.86

See More

52-Week High 4.38
Last Price 3.63
Fibonacci 61.8% 3.30
Fibonacci 50% 2.97
Fibonacci 38.2% 2.64
52-Week Low 1.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar